@article{10.37349/eemd.2026.101471,
abstract = {Metabolic diseases, including obesity, insulin resistance, and type 2 diabetes mellitus, are increasingly recognized as conditions characterized by chronic low-grade inflammation driven by dysregulated cytokine signaling. Persistent elevation of pro-inflammatory mediators disrupts insulin signaling and contributes to metabolic dysfunction. Nutritional interventions capable of restoring cytokine balance are emerging as promising adjunct strategies for metabolic disease management. Chickpea (Cicer arietinum L.), a widely consumed legume, is rich in polyphenols, saponins, dietary fiber, and bioactive peptides with potential immunometabolic benefits. This review critically summarizes the role of chickpea bioactives in modulating cytokine signaling networks, with particular emphasis on the IL-6-JAK-STAT3-SOCS3 axis and NF-κB pathway. Chickpea components exert antioxidant and anti-inflammatory effects, suppress pro-inflammatory cytokine production, and may improve insulin sensitivity. Additionally, their potential chemoprotective effects in obesity-associated metabolic disorders are discussed. Furthermore, this review highlights key gaps in mechanistic and translational research and proposes future directions for pathway-oriented investigations. Although current evidence supports the therapeutic potential of chickpea, further mechanistic and clinical validation is required.},
author = {Khan, Shahied Ahmed and Chib, Shivani},
doi = {10.37349/eemd.2026.101471},
journal = {Exploration of Endocrine and Metabolic Diseases},
elocation-id = {101471},
title = {Chickpea (Cicer arietinum L.) bioactives modulate dysregulated cytokine signaling pathways in metabolic disease},
url = {https://www.explorationpub.com/Journals/eemd/Article/101471},
volume = {3},
year = {2026}
}